Analgesic Infusion Pumps Market By Application (Accidents & Trauma, Cancer Patients, Post Surgical Applications, Labor Pain), By Products (Syringe Analgesia Infusion Pumps, Ambulatory Analgesia Infusion Pumps, Volumetric Analgesia Infusion Pumps), Industry Size, Growth, Share And Forecast To 2022
Key Findings
The global analgesic infusion pumps market has been growing at an impressive rateduring the forecasted period of 2016-2022. Analgesic infusion pumps are the equipments used to inject analgesic drugs directly into patient’s body. Analgesic drugs ensure relief from chronic disorders, including failed back syndrome pain, hypertension, post-operative pain, myocardial ischemia, pneumonia, myocardial infarction and complex regional pain syndrome (CRPS). Phenol, morphine and lidocaine are some of the general medicines utilized in the analgesic infusion pumps. The device is produced to deliver suitable quantity of medication, whenever required. As analgesia infusion pumps enables patients to maintain pre-set amount of analgesic medication, the devices are also named as patient controlled analgesia (PCA). The analgesic infusion pumps can also be fixed inside the patient’s body or can be utilized as an external device also.
The key factors contributing for the growth of analgesic infusion pumps market are rising chronic diseases, usage of analgesia pump for pain management, government investment for the establishment of new manufacturing plant, rising application in the treatment of various neurological situations such as cerebral palsy and spinal cord injury, technological advancements and rising awareness due to advantages concerned with analgesia infusion pumps. Problems regarding the usage in aging population has been the major restraint in the market.The market has huge opportunities such as large presence of qualified and skilled professionals in emerging nations and growing medical tourism in emerging nations such as China & India There has been a rise in the technological advancements in the healthcare sector that has been increasing the scope of analgesic infusion pumps market. The market is facinga major challenge i.e. of stringent FDA regulations.
Market Segment Insight
Analgesic infusion market has been segmented on the basis of application, products and geography. On the basis of application, the market is segmented into accidents & trauma, cancer patients, post surgical applications, labor pain and other applications. On the basis of products, the market is segmented into syringe analgesia infusion pumps, ambulatory analgesia infusion pumps, volumetric analgesia infusion pumps and others. Ambulatory analgesic pumps market has been estimated to witness high growth rate over the forecasted period due to rising demand for these pumps.
Regional Insight
On the basis of geography, the market has been segmented into North America, Europe, Asia Pacific and RoW. Currently, North America is the leader in the global analgesic infusion pumps market and it is being followed by Europe. More key factors responsible for the fast development of the analgesia infusion pumps market in the North America regions are higher adoption rate of technically advanced therapeutic tools, availability of reimbursement policies, high healthcare spending and highly developed healthcare infrastructure. Asia-Pacific has beenestimated as an effective market for analgesia infusion pumps owing to rapid developing healthcare infrastructure, increasing healthcare spending and rising government support for rising awareness about the presence of medical facilities in the country through developing medical tourism industries particularly in countries like China and India. Moreover, presence of qualified and skilled professionals at lower rates as compared to developed nations and presence of government investmentforthe introduction new manufacturing plants are some of key factors that has been estimated to attract the global analgesia infusion pumps producers to the Asia-Pacific region.
Competitive Insights
Some of the major players in the global analgesic infusion pumps market are: Animas Corporation, B. Braun Melsungen AG, Baxter International Inc., Beijing Wondcon Technology Co. ltd, Caesarea medical electronics, CareFusion Corporation,Fresenius Kabi AG, Hospira, Inc., KD Scientific, Inc., Medtronic Inc.,Shaanxi Aipu medical Instruments Co. Ltd, Shanghai berry Electronic Technology Co. Ltd, Smiths Medical, Terumo Corporation, Zhejiang Runqiang Medical Instruments Co. Ltd etc. These key players has adopted various key strategies such as mergers, acquisitions, partnership, product launch etc. to expand their market share globally.On May 2016, Hospira launches LifeCare PCA® 7.0 Infusion System, with first PCA pump that integrates theelectronic medical record. It is the first patient-controlled analgesia (PCA) infusion pump to provide EMR (electronic medical record) integration which is also known as I.V.-EMR interoperability. It allows streamline documentation and device auto-programming of infusion data to support for the development of the safety and effectiveness of pain management medication administration.
CHAP 1. METHODOLOGY & SCOPE 12
1.1. RESEARCH METHODOLOGY 12
1.2. RESEARCH SCOPE & ASSUMPTIONS 12
1.3. LIST OF DATA SOURCES 12
CHAP 2. EXECUTIVE SUMMARY 13
2.1. GLOBAL ANALGESIC INFUSION PUMPS MARKET SUMMARY & KEY BUYING CRITERIA 13
2.2. GLOBAL ANALGESIC INFUSION PUMPS MARKET OUTLOOK 13
2.3. MARKET SEGMENTATION ANALYSIS 13
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 13
2.5. GLOBAL ANALGESIC INFUSION PUMPS MARKET VALUE CHAIN ANALYSIS 13
2.6. VENDOR LANDSCAPE 13
CHAP 3. GLOBAL ANALGESIC INFUSION PUMPS MARKET 14
3.1. MARKET DRIVER ANALYSIS 14
3.1.1. RISING CHRONIC DISEASES AND USAGE OF ANALGESIA PUMP FOR PAIN MANAGEMENT. 14
3.1.2. GOVERNMENT INVESTMENT FOR THE ESTABLISHMENT OF NEW MANUFACTURING PLANT 14
3.1.3. RISING APPLICATION IN THE TREATMENT OF VARIOUS NEUROLOGICAL SITUATIONS SUCH AS CEREBRAL PALSY AND SPINAL CORD INJURY. 14
3.1.4. TECHNOLOGICAL ADVANCEMENT 14
3.1.5. RISING AWARENESS DUE TO ADVANTAGES CONCERNED WITH ANALGESIA INFUSION PUMPS 14
3.2. MARKET RESTRAINT ANALYSIS 14
3.2.1. PROBLEMS REGARDING THE USAGE IN AGING POPULATION. 14
3.3. KEY OPPORTUNITIES 14
3.3.1. GROWING MEDICAL TOURISM IN EMERGING NATIONS SUCH AS CHINA & INDIA. 14
3.3.2. PRESENCE OF QUALIFIED AND SKILLED PROFESSIONALS IN EMERGING NATIONS. 14
3.4. CHALLENGES 14
3.4.1. STRINGENT FDA REGULATIONS 14
CHAP 4. INDUSTRY ANALYSIS 15
4.1. GLOBAL ANALGESIC INFUSION PUMPS MARKET– PORTER’S FIVE FORCE MODEL 15
4.2. GLOBAL ANALGESIC INFUSION PUMPS MARKET– PESTEL ANALYSIS 15
4.3. GLOBAL ANALGESIC INFUSION PUMPS MARKET– GAP ANALYSIS 15
CHAP 5. GLOBAL ANALGESIC INFUSION PUMPS MARKET BY APPLICATION 2012-2022 ($ MILLION) 16
5.1. GLOBAL ANALGESIC INFUSION PUMPS MARKET BY ACCIDENTS & TRAUMA 2012-2022 ($ MILLION) 16
5.2. GLOBAL ANALGESIC INFUSION PUMPS MARKET BY CANCER PATIENTS 2012-2022 ($ MILLION) 16
5.3. GLOBAL ANALGESIC INFUSION PUMPS MARKET BY POST SURGICAL APPLICATIONS 2012-2022 ($ MILLION) 16
5.4. GLOBAL ANALGESIC INFUSION PUMPS MARKET BY LABOR PAIN 2012-2022 ($ MILLION) 16
5.5. GLOBAL ANALGESIC INFUSION PUMPS MARKET BY OTHER APPLICATIONS 2012-2022 ($ MILLION) 16
CHAP 6. GLOBAL ANALGESIC INFUSION PUMPS MARKET BY PRODUCTS 2012-2022 ($ MILLION) 17
6.1. GLOBAL ANALGESIC INFUSION PUMPS MARKET BY SYRINGE ANALGESIA INFUSION PUMPS 2012-2022 ($ MILLION) 17
6.2. GLOBAL ANALGESIC INFUSION PUMPS MARKET BY AMBULATORY ANALGESIA INFUSION PUMPS 2012-2022 ($ MILLION) 17
6.3. GLOBAL ANALGESIC INFUSION PUMPS MARKET BY VOLUMETRIC ANALGESIA INFUSION PUMPS 2012-2022 ($ MILLION) 17
6.4. GLOBAL ANALGESIC INFUSION PUMPS MARKET BY OTHERS 2012-2022 ($ MILLION) 17
CHAP 7. GLOBAL ANALGESIC INFUSION PUMPS MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 18
7.1. GLOBAL ANALGESIC INFUSION PUMPS MARKET BY REGION 2012-2022 ($ MILLION) 18
7.2. NORTH AMERICA 18
7.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 18
7.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 18
7.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 18
7.2.3.1. U.S. 18
7.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 18
7.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 18
7.2.3.2. CANADA 18
7.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.3. EUROPE 19
7.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 19
7.3.3.1. GERMANY 19
7.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.3.3.2. UK 19
7.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.3.3.3. FRANCE 19
7.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.3.3.4. SPAIN 19
7.3.3.4.1. SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
7.3.3.4.2. SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
7.3.3.5. REST OF EUROPE 19
7.3.3.5.1. RUSSIA MARKET ESTIMATES AND FORECAST2012-2022($MILLION) 20
7.3.3.5.2. RUSSIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 20
7.3.3.5.3. OTHERS MARKET ESTIMATES AND FORECAST2012-2022($MILLION) 20
7.3.3.5.4. OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 20
7.4. ASIA PACIFIC 20
7.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 20
7.4.3.1. CHINA 20
7.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.4.3.2. INDIA 20
7.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
7.4.3.3. JAPAN 20
7.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
7.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 20
7.4.3.4. SOUTH KOREA 20
7.4.3.4.1. SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.4.3.4.2. SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 21
7.4.3.5. OTHERS 21
7.4.3.5.1. OTHER MARKET ESTIMATES AND FORECASTS 2012-2022($MILLION) 21
7.4.3.5.2. OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 21
7.5. MIDDLE EAST & AFRICA 21
7.5.1. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.5.2. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.6. LATIN AMERICA 21
7.6.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.6.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
7.6.2.1. BRAZIL 21
7.6.2.1.1. BRAZIL MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
7.6.2.1.2. BRAZIL MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
CHAP 8. COMPETITIVE LANDSCAPE 22
8.1. ANIMAS CORPORATION 23
8.1.1. COMPANY OVERVIEW 23
8.1.2. SCOT ANALYSIS 23
8.1.3. PRODUCT BENCHMARKING 23
8.1.4. STRATEGIC INITIATIVES 23
8.2. B. BRAUN MELUNGEN AG 23
8.2.1. COMPANY OVERVIEW 23
8.2.2. SCOT ANALYSIS 23
8.2.3. PRODUCT BENCHMARKING 23
8.2.4. STRATEGIC INITIATIVES 23
8.3. BAXTER INTERNATIONAL INC. 23
8.3.1. COMPANY OVERVIEW 23
8.3.2. SCOT ANALYSIS 23
8.3.3. PRODUCT BENCHMARKING 23
8.3.4. STRATEGIC INITIATIVES 23
8.4. BEIJING WONDCON TECHNOLOGY CO. LTD 23
8.4.1. COMPANY OVERVIEW 23
8.4.2. SCOT ANALYSIS 23
8.4.3. PRODUCT BENCHMARKING 23
8.4.4. STRATEGIC INITIATIVES 23
8.5. CAESAREA MEDICAL ELECTRONICS 23
8.5.1. COMPANY OVERVIEW 23
8.5.2. SCOT ANALYSIS 23
8.5.3. PRODUCT BENCHMARKING 23
8.5.4. STRATEGIC INITIATIVES 23
8.6. CAREFUSION CORPORATION 23
8.6.1. COMPANY OVERVIEW 23
8.6.2. SCOT ANALYSIS 24
8.6.3. PRODUCT BENCHMARKING 24
8.6.4. STRATEGIC INITIATIVES 24
8.7. FRESENIUS KABI AG 24
8.7.1. COMPANY OVERVIEW 24
8.7.2. SCOT ANALYSIS 24
8.7.3. PRODUCT BENCHMARKING 24
8.7.4. STRATEGIC INITIATIVES 24
8.8. HOSPIRA INC. 24
8.8.1. COMPANY OVERVIEW 24
8.8.2. SCOT ANALYSIS 24
8.8.3. PRODUCT BENCHMARKING 24
8.8.4. STRATEGIC INITIATIVES 24
8.9. KD SCIENTIFIC INC. 24
8.9.1. COMPANY OVERVIEW 24
8.9.2. SCOT ANALYSIS 24
8.9.3. PRODUCT BENCHMARKING 24
8.9.4. STRATEGIC INITIATIVES 24
8.10. MEDTRONIC INC. 24
8.10.1. COMPANY OVERVIEW 24
8.10.2. SCOT ANALYSIS 24
8.10.3. PRODUCT BENCHMARKING 24
8.10.4. STRATEGIC INITIATIVES 24
8.11. SHAANXI AIPU MEDICAL INSTRUMENTS CO. LTD 24
8.11.1. COMPANY OVERVIEW 24
8.11.2. SCOT ANALYSIS 24
8.11.3. PRODUCT BENCHMARKING 24
8.11.4. STRATEGIC INITIATIVES 24
8.12. SHANGHAI BERRY ELECTRONIC TECHNOLOGY CO. LTD 25
8.12.1. COMPANY OVERVIEW 25
8.12.2. SCOT ANALYSIS 25
8.12.3. PRODUCT BENCHMARKING 25
8.12.4. STRATEGIC INITIATIVES 25
8.13. SMITHS MEDICAL 25
8.13.1. COMPANY OVERVIEW 25
8.13.2. SCOT ANALYSIS 25
8.13.3. PRODUCT BENCHMARKING 25
8.13.4. STRATEGIC INITIATIVES 25
8.14. TERUMO CORPORATION 25
8.14.1. COMPANY OVERVIEW 25
8.14.2. SCOT ANALYSIS 25
8.14.3. PRODUCT BENCHMARKING 25
8.14.4. STRATEGIC INITIATIVES 25
8.15. ZHEJIANG RUNQIANGMEDICAL INSTRUMENTS CO. LTD 25
8.15.1. COMPANY OVERVIEW 25
8.15.2. SCOT ANALYSIS 25
8.15.3. PRODUCT BENCHMARKING 25
8.15.4. STRATEGIC INITIATIVES 25
TABLE 1 GLOBAL ANALGESIC INFUSION PUMPS MARKET BY APPLICATION 2012-2022 ($ MILLION) 25
TABLE 2 GLOBAL ANALGESIC INFUSION PUMPS MARKET BY ACCIDENTS & TRAUMA 2012-2022 ($ MILLION) 25
TABLE 3 GLOBAL ANALGESIC INFUSION PUMPS MARKET BY CANCER PATIENTS 2012-2022 ($ MILLION) 25
TABLE 4 GLOBAL ANALGESIC INFUSION PUMPS MARKET BY POST SURGICAL APPLICATIONS 2012-2022 ($ MILLION) 25
TABLE 5 GLOBAL ANALGESIC INFUSION PUMPS MARKET BY LABOR PAIN 2012-2022 ($ MILLION) 26
TABLE 6 GLOBAL ANALGESIC INFUSION PUMPS MARKET BY OTHER APPLICATIONS 2012-2022 ($ MILLION) 26
TABLE 7 GLOBAL ANALGESIC INFUSION PUMPS MARKET BY PRODUCTS 2012-2022 ($ MILLION) 26
TABLE 8 GLOBAL ANALGESIC INFUSION PUMPS MARKET BY SYRINGE ANALGESIA INFUSION PUMPS 2012-2022 ($ MILLION) 26
TABLE 9 GLOBAL ANALGESIC INFUSION PUMPS MARKET BY AMBULATORY ANALGESIA INFUSION PUMPS 2012-2022 ($ MILLION) 26
TABLE 10 GLOBAL ANALGESIC INFUSION PUMPS MARKET BY VOLUMETRIC ANALGESIA INFUSION PUMPS 2012-2022 ($ MILLION) 26
TABLE 11 GLOBAL ANALGESIC INFUSION PUMPS MARKET BY OTHERS 2012-2022 ($ MILLION) 26
TABLE 12 GLOBAL ANALGESIC INFUSION PUMPS MARKET, REGIONAL OUTLOOK 2012-2022 ($ MILLION) 26
TABLE 13 GLOBAL ANALGESIC INFUSION PUMPS MARKET BY REGION 2012-2022 ($ MILLION) 26
TABLE 14 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
TABLE 15 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
TABLE 16 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 26
TABLE 17 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
TABLE 18 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
TABLE 19 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
TABLE 20 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
TABLE 21 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
TABLE 22 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 27
TABLE 23 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
TABLE 24 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
TABLE 25 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
TABLE 26 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
TABLE 27 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
TABLE 28 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
TABLE 29 FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
TABLE 30 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
TABLE 31 SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
TABLE 32 RUSSIA MARKET ESTIMATES AND FORECAST2012-2022 ($ MILLION) 27
TABLE 33 RUSSIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
TABLE 34 OTHERS MARKET ESTIMATES AND FORECAST2012-2022 ($ MILLION) 27
TABLE 35 OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ( $ MILLION) 27
TABLE 36 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
TABLE 37 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
TABLE 38 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 27
TABLE 39 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 40 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 41 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 42 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 43 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 44 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 45 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 46 SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 47 OTHER MARKET ESTIMATES AND FORECASTS 2012-2022 ($ MILLION) 28
TABLE 48 OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 49 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 50 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 51 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 52 LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
TABLE 53 BRAZIL MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
TABLE 54 BRAZIL MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
FIGURE 1 MARKET SHARE BY REGIONS 28
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 4 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 5 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 6 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 7 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 8 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 9 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 10 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 11 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 12 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 13 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 14 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 15 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
FIGURE 16 BRAZIL AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 29
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)